Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2024-12-30 00:00:00 ET · period of report 2024-12-27 · accession 0001628280-24-052575 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-30 | 2024-12-27 | SUPN | Rubin Jonathan | SVP, Chief Medical Off | M - OptEx | $0.00 | +2,625 | 7,416 | +55% | $0 |
| DM | 2024-12-30 | 2024-12-27 | SUPN | Rubin Jonathan | SVP, Chief Medical Off | F - Tax | $35.59 | -1,102 | 6,595 | -14% | -$39.2K |
| DM | 2024-12-30 | 2024-12-27 | SUPN | Rubin Jonathan | SVP, Chief Medical Off | M - OptEx | $0.00 | -2,625 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-27 | M | A | 750 | $0.00 | 5,822 | D | — | — | (F1) Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 23, 2023. (F2) Includes an aggregate of 431 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2024-12-27 | F | D | 281 | $35.59 | 5,541 | D | — | — | (F3) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. |
| 3 | Common | Common Stock | 2024-12-27 | M | A | 1,875 | $0.00 | 7,416 | D | — | — | (F4) Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024. |
| 4 | Common | Common Stock | 2024-12-27 | F | D | 821 | $35.59 | 6,595 | D | — | — | (F3) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. |
| 5 | Derivative | Performance Share Unit | 2024-12-27 | M | D | 1,875 | $0.00 | 0 | D | $0.00 · — to — | 1,875 Common Stock | (F6) On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. |
| 6 | Derivative | Performance Share Unit | 2024-12-27 | M | D | 750 | $0.00 | 0 | D | $0.00 · — to — | 750 Common Stock | (F5) On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023 and modified on December 12, 2024. |